Navigation Links
Macrocyclics introduces new products
Date:1/10/2014

DALLAS, Jan. 10, 2014 /PRNewswire/ -- Macrocyclics, Inc. (an AREVA Med company) announced today the introduction of four new products that will expand PET imaging applications with copper-64 and gallium-68 using NOTA-based chelating platforms. In addition, a new serotonin-based DOTA conjugate offers the potential to image serotoninergic neurotransmission using a radioisotope or with gadolinium by magnetic resonance imaging (MRI).

(Logo: http://photos.prnewswire.com/prnh/20130523/DA20136LOGO)

Please visit www.macrocyclics.com for detailed information.

MORE ABOUT MACROCYCLICS  
Macrocyclics is the global leader in high performance chelating agent technologies for medicine since 1995.  Our team at Macrocyclics is dedicated to providing clients with both established and innovative chelating agents and services to meet the challenges of molecular imaging and nuclear medicine.  www.macrocyclics.com

MORE ABOUT AREVA MED  
AREVA Med is an AREVA subsidiary specializing in the development of innovative therapies to fight cancer. AREVA Med has developed new processes for producing high purity lead-212 (²¹²Pb), a rare metal that is currently at the heart of promising nuclear medicine research.  In 2011, AREVA Med acquired Macrocyclics, the global leader in high performance chelating agent technology.  AREVA Med is also associated with world-class scientific partners, such as the National Cancer Institute (NCI), the University of Alabama at Birmingham (UAB), and the French National Institute of Health and Medical Research (Inserm). In 2012, AREVA Med and Roche entered a strategic alliance to create novel advanced alpha radioimmunotherapy treatments to target and kill certain very aggressive types
'/>"/>

SOURCE Macrocyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. IRIDEX Introduces Non-Invasive MicroPulse™ Therapy for Glaucoma
2. Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in Gastroenterology Portfolio
3. Richard Wolf Medical Instruments introduces groundbreaking 5514 Endocam Performance HD
4. Rochester Medical Introduces Magic3® Coude Tip Hydrophilic Intermittent Catheter
5. Velos, Inc. Introduces Mobile App for Oncology Adverse Events and Graft-Versus-Host Disease at 2012 ASCO Annual Meeting
6. IDEV Technologies Introduces SurePath™ Guidewires
7. ConvaTec Introduces Enhanced Flexi-Seal® SIGNAL® FMS
8. HealthONE® Introduces the Colorado Center for Robotic Surgery(SM)
9. PeriGen, Inc. Introduces New, Advanced Perinatal System at National Perinatal Nursing Convention
10. PharmaNet/i3 Introduces PharmaNet/i3 Strategic Resourcing
11. Zimmer Introduces First Porous Metal Interbody Implant for Lumbar Spine in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 18, 2014 Baptist Health Lexington is the first ... receive full Atrial Fibrillation with Electrophysiology Services (EPS) Accreditation status ... Atrial fibrillation is the most common cardiac arrhythmia and has ... can lead to stroke and possible death. More than 5 ... have atrial fibrillation and the numbers are rapidly increasing as ...
(Date:12/19/2014)... 2014   Aratana Therapeutics, Inc . (NASDAQ: ... on the licensing, development and commercialization of innovative ... from its pivotal field study of AT-001 (Grapiprant), ... dogs with osteoarthritis.  In the study, dogs receiving ... were statistically significant compared to placebo (p<0.05) at ...
(Date:12/19/2014)... separating membrane market has witnessed robust development with ... albeit as a later starter. In 2012, the size of ... RMB12 billion, with the proportion worldwide soaring to 16.3%. It ... market will continue its growth rate by around 20% in ... jump to roughly RMB25 billion. An integrated membrane ...
Breaking Medicine Technology:Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 3
... MELBOURNE, Fla. and BALTIMORE, March 15, 2011 ... venture to innovate, implement and commercialize next generation of ... brings together leading clinicians and advanced engineering technologists. ... ), an international communications and information technology company, and ...
... (Nasdaq: CPHD ) today announced that Glenn Steele, ... Board of Directors at the company,s Annual Meeting of Shareholders ... Steele has been President and Chief Executive Officer of Geisinger ... of Pennsylvania, since 2001.  Before that, Dr. Steele served as ...
Cached Medicine Technology:Harris Corporation and Johns Hopkins Medicine Announce Joint Venture to Develop Innovative Medical Image Management Solutions 2Cepheid Announces Nomination of Geisinger Health System CEO and Renowned Oncology Researcher to Board of Directors 2Cepheid Announces Nomination of Geisinger Health System CEO and Renowned Oncology Researcher to Board of Directors 3
(Date:12/19/2014)... (HealthDay News) -- Potentially illness-causing E. coli bacteria were ... markets, according to a new study. Researchers checked ... 13 farmers markets in Los Angeles and Orange counties ... almost 150 samples tested, 24 percent were positive for ... to the researchers. Both types of bacteria can ...
(Date:12/19/2014)... FRIDAY, Dec. 19, 2014 (HealthDay News) -- Dense bunches of ... and cancers, a new study finds. The researchers ... of the colon. The presence of these biofilms may ... a new way to predict a person,s risk for the ... on pond stones, these biofilms may coat the mucus layer ...
(Date:12/19/2014)... FRIDAY, Dec. 19, 2014 (HealthDay News) -- Older adults who ... and walking ability than people who still have at least ... findings suggest that total tooth loss could provide an early ... older people, the British researchers said. However, the findings ... decline. The study included more than 3,100 participants 60 ...
(Date:12/19/2014)... Diet Doc strives to continue to ... weight loss by combining scientific fast weight ... the company understand that remaining committed to a diet ... carbohydrates and sugars from the diet can cause patients ... weight loss goals. , For this reason, Diet ...
(Date:12/19/2014)... December 19, 2014 B. E. Smith, ... healthcare providers, has been retained to lead a national ... Medical Center in Estes Park, Colo. The top executive ... has recently placed more than 900 healthcare executives into ... a 25-bed, not-for-profit critical access hospital and level IV ...
Breaking Medicine News(10 mins):Health News:E. Coli Germs Found on Farmers Market Herbs 2Health News:Could Bacteria Play a Role in Colon Cancer? 2Health News:Loss of Teeth Linked to Physical, Mental Decline in Study 2Health News:Diet Doc Incorporates Appetite Zap into their Already Impressive Collection of Diet Products to Jump Start the Metabolism and Burn Fat 4X Faster 2Health News:Diet Doc Incorporates Appetite Zap into their Already Impressive Collection of Diet Products to Jump Start the Metabolism and Burn Fat 4X Faster 3Health News:Diet Doc Incorporates Appetite Zap into their Already Impressive Collection of Diet Products to Jump Start the Metabolism and Burn Fat 4X Faster 4Health News:Estes Park Medical Center Retains B. E. Smith to Recruit New Chief Financial Officer 2Health News:Estes Park Medical Center Retains B. E. Smith to Recruit New Chief Financial Officer 3
... ... nuts? It,s simple, with a new E-card from Snoring Isn,t Sexy®. Telling someone he or she ... a series of expletives. , ... 27, 2009 -- What,s the perfect way to tell a loved one that their snoring is ...
... , , , TOSU, Saga, ... 4530) and Hisamitsu U.S., Inc. today announced the completion of their ... of Northstar Merger Sub, Inc., a wholly owned subsidiary of Hisamitsu ... Pursuant to the Agreement and Plan of Merger among ...
... , THOUSAND OAKS, Calif., Aug. 27 The ... biggest breakthrough skin l a ser treatment ... . In Los Angeles, beautiful looking skin is a virtue that can ... flawless skin that cosmetic surgery is practically a must for individuals in ...
... drug might slow the destructive lung condition, studies show ... there is no cure for chronic obstructive pulmonary disease ... illness and add years to the lives of sufferers, ... disease of the lungs that is usually brought on ...
... , , , ... MPA Media today announced the launch of a new magazine in ... decisions. , , "MPA Media is fortunate ... by more and more consumers. The most recent research shows that ...
... , , 31 Attorneys General ... , WASHINGTON, Aug. 27 The American Health Care ... letter to Health and Human Services Secretary Kathleen Sebelius, calling for ... Services (CMS,) Nursing Home Five Star Rating System. , ...
Cached Medicine News:Health News:Snoring Isn't Sexy, LLC Announces the Launch of E-cards for Snorers 2Health News:Hisamitsu Pharmaceutical Completes Acquisition of Noven Pharmaceuticals 2Health News:Los Angeles Clinic (laserandveinclinic.com) Offers the Latest Laser Skin Rejuvenation Treatments 2Health News:Treating COPD Early Improves Outcomes 2Health News:Treating COPD Early Improves Outcomes 3Health News:Treating COPD Early Improves Outcomes 4Health News:MPA Media Launches New Chiropractic Publication, Dynamic Chiropractic PracticeINSIGHTS 2Health News:CMS' Five Star Nursing Home Rating System Called Into Question Once Again 2
High EEO (-mr) (0.23-0.26), suitable for IEP, Gel point (1.5%): 36 1.5 °C Gel strength (1%): > 750 g/cm2....
Excellent multi purpose agarose Nuclease-free, Gel point (1.5%): 36 1.5 C, EEO: 0.05-0.13 Gel strength (1%): > 1200 g/cm 2 ....
... non-ionic fraction of agar. Forms gel with ... Can be mounted on microscope slides or ... and durable and show little or no ... lipoprotein dyes. Contaminants: ash: ...
... PCR agarose is recommended for separations of ... forms gels that are easy to handle, ... percentages, which minimizes the risk of cracking ... quality tested (GQT) products with similar sieving ...
Medicine Products: